Product news

Share this article:
Teva Pharmaceuticals announced the introduction and availability of Quinapril tablets. The product is the bioequivalent to Pfizer's Accupril tablets. Quinapril tablets are available in 5 mg, 10 mg, 20 mg, and 40 mg strengths, in bottle sizes of 90 and 500.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Researchers hit links for charity

The PMR Charities Golf Classic teed up more than $20,000 for St. Jude Children's Research Hospital.

FDA to review Neupogen biosimilar

Novartis subsidiary Sandoz announced Thursday that the FDA has agreed to review its filgrastim biosimilar which is already approved in 40 countries.

FDA approves a new painkiller

Targiniq ER combines the prescription opioid oxycodone and naloxone, which is often used to treat overdoses.